Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02022670 · ClinicalTrials.gov registry record · Phase 1
Sodium Nitrite to Treat Arterial Aging
A Phase 1 study, sponsored by University of Colorado, Boulder.
- Completed
- Registry status
- Phase 1
- Development phase
- 33
- Enrollment target
NCT02022670 is a Phase 1 study that has completed, run by University of Colorado, Boulder. The registered enrollment target is 33 participants.
The verdict
NCT02022670, a Phase 1 study, has completed, sponsored by University of Colorado, Boulder.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 33 participants
- Enrollment target
Study Summary
The proposed research will determine the effectiveness of nitrite, a naturally occurring compound in the body, for improving the health and function of arteries in middle-aged and older adults. The study also will provide insight into how sodium nitrite therapy improves artery health by determining the physiological mechanisms (biological reasons) involved. Overall, the proposed research will provide important new scientific evidence on the effectiveness of sodium nitrite for decreasing the risk of developing cardiovascular diseases with aging.
Interventions
- DRUG Placebo
- DRUG Sodium Nitrite
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 33 participants |
| Start Date | 2011-10 |
| Est. Completion | 2013-12 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02022670
The ClinicalTrials.gov registry entry for NCT02022670 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 33 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Colorado, Boulder, which has 69 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT02022670 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02022670 about?
NCT02022670 is a clinical study titled "Sodium Nitrite to Treat Arterial Aging". The proposed research will determine the effectiveness of nitrite, a naturally occurring compound in the body, for improving the health and function of arteries in middle-aged and older adults. The study also will provide insight into how sodium nitrite therapy improves artery health by determining ...
What is the current status of trial NCT02022670?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 33 participants. The study started on 2011-10. Estimated completion is 2013-12.
What interventions are being tested in trial NCT02022670?
The interventions under investigation include: Placebo (DRUG), Sodium Nitrite (DRUG).
Who is sponsoring clinical trial NCT02022670?
This trial is sponsored by University of Colorado, Boulder, which has 69 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.